Hepatitis B Virus : The Quest for Global Control and Eradication. Satellite Symposium. Toronto, ON, CAN, 1997/09.
THE PEDIATRIC INFECTIOUS DISEASE JOURNAL, vol. 17, n° 7, Suppl., 1998, page S38-S42, 12 réf., ISSN 0891-3668, USA
There are numerous strategies recommended in the United States for control of the hepatitis B virus, including universal vaccination of infants and adolescents and vaccination of all high risk populations.
A recent hepatitis B vaccination program conducted in Philadelphia, PA, focused on effective ways to educate and vaccinate the high risk Asian Pacific Islander population.
Multiple intervention activities were used for both health care providers and Asian Pacific Islander community members, including one-to-one educational programs.
Intervention activities did increase hepatitis B vaccination coverage to 34%, but coverage increase was less than has been shown with other programs.
The intervention program, however, may have a long-lasting positive impact on vaccination coverage because postintervention, study participant health care providers began to offer a more flexible vaccination delivery system.
It is likely that the total cost of $135 943 for all intervention activities will prevent future costly cases of chronic hepatitis B and its serious related sequelae among this high risk population.
Mots-clés BDSP : Hépatite virale B, Virose, Infection, Virus, Programme élargi vaccination, Programme santé, Océanie, Vaccination, Coût, Homme, Appareil digestif [pathologie], Foie [pathologie], Prévention
Mots-clés Pascal : Hépatite virale B, Virose, Infection, Virus hépatite B, Orthohepadnavirus, Hepadnaviridae, Virus, Programme sanitaire, Iles du Pacifique us, Océanie, Vaccination, Immunoprophylaxie, Coût, Indication, Homme, Couverture, Appareil digestif pathologie, Foie pathologie, Prévention
Mots-clés Pascal anglais : Viral hepatitis B, Viral disease, Infection, Hepatitis B virus, Orthohepadnavirus, Hepadnaviridae, Virus, Sanitary program, Pacific Islands Us, Oceania, Vaccination, Immunoprophylaxis, Costs, Indication, Human, Coverage, Digestive diseases, Hepatic disease, Prevention
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0482954
Code Inist : 002B05C02G. Création : 19/02/1999.